Tetsuya Fujita
Overview
Explore the profile of Tetsuya Fujita including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
82
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Okada H, Tanaka M, Yasuda T, Okada Y, Norikae H, Fujita T, et al.
Sci Rep
. 2021 Jan;
11(1):2135.
PMID: 33483575
Cardiovascular disease (CVD) is still the major cause of mortality in patients with type 2 diabetes. Despite of recent therapies, mortality and resources spent on healthcare due to CVD is...
2.
Okada H, Tanaka M, Yasuda T, Okada Y, Norikae H, Fujita T, et al.
Sci Rep
. 2020 Apr;
10(1):6054.
PMID: 32269240
Diabetic kidney disease (DKD) is one of the leading causes of end stage renal disease. Despite recent therapies, mortality due to DKD and resources spent on healthcare are important problems....
3.
Okada H, Tanaka M, Yasuda T, Okada Y, Norikae H, Fujita T, et al.
Heart Vessels
. 2020 Feb;
35(7):930-935.
PMID: 32062766
Background: The importance of microcirculation for adverse outcomes in the early phase of critical illnesses has been reported. Microcirculatory function is assessed using the perfusion index (PI), which represents the...
4.
Okada H, Tanaka M, Yasuda T, Okada Y, Norikae H, Fujita T, et al.
J Diabetes Investig
. 2019 Nov;
11(3):681-687.
PMID: 31778299
Aims/introduction: Diabetic kidney disease has been considered as an important risk factor of cardiovascular disease. Chronic hypoxia is considered to be the main cause of renal injury. Diminished microcirculatory blood...
5.
Takeuchi Y, Fujita T, Takeyasu N
Phys Chem Chem Phys
. 2019 Mar;
21(14):7502-7507.
PMID: 30893415
Surface-enhanced Raman scattering (SERS) spectra of organic compounds, para-methylthiophenol (p-MT), decylamine and 1-butanethiol (1-BT), were measured using a two-dimensional silver nanoparticle array at 532 nm excitation. For p-MT, it was...
6.
Okada H, Tanaka M, Yasuda T, Kamitani T, Norikae H, Fujita T, et al.
Heart Vessels
. 2018 Oct;
34(4):583-589.
PMID: 30284017
The number of people with peripheral artery disease (PAD) has been increasing globally; therefore, it is important to explore more options to screen patients who are at a risk of...
7.
Seino Y, Fujita T, Hiroi S, Hirayama M, Kaku K
Curr Med Res Opin
. 2011 Nov;
27 Suppl 3:21-9.
PMID: 22106975
Objective: To compare the efficacy and safety of alogliptin and placebo as add-on therapy in Japanese patients with type 2 diabetes who experienced inadequate glycemic control on voglibose plus diet/exercise...
8.
Seino Y, Fujita T, Hiroi S, Hirayama M, Kaku K
Curr Med Res Opin
. 2011 Aug;
27(9):1781-92.
PMID: 21806314
Objective: To compare the efficacy and safety of different dosages of alogliptin with that of placebo and voglibose in drug-naïve Japanese patients with type 2 diabetes inadequately controlled by diet...
9.
Takeuchi K, Fujita T, Hiroi S
Nihon Yakurigaku Zasshi
. 2011 Jan;
137(1):43-50.
PMID: 21233588
No abstract available.
10.
Kurata T, Matsuo K, Takada M, Kawahara M, Tsuji M, Matsubara Y, et al.
J Thorac Oncol
. 2007 Apr;
1(7):684-91.
PMID: 17409937
Background: It is controversial whether achieving stable disease leads to a survival benefit and whether the importance of achieving stable disease differs between cytotoxic agents and molecular targeted agents. To...